Advertisement
Original Contribution
JAMA. 1978;239(3):213-216. doi: 10.1001/jama.1978.03280300045019

Cardiovascular Effects of Tricyclic and Tetracyclic Antidepressants

  1. Dieter Burckhardt, MD;
  2. Ernst Raeder, MD;
  3. Verena Müller, MD;
  4. Peter Imhof, MD;
  5. Hans Neubauer, MD
  1. From the Departments of Internal Medicine, Cardiology Section (Drs Burckhardt and Raeder) and Psychiatry (Drs Müller and Neubauer), University Hospital, Basel, Switzerland, and the Department of Pharmacology, Ciba-Geigy, Basel, Switzerland.

Abstract

Cardiovascular effects of therapeutic doses of tricyclic or tetracyclic antidepressants (TCA) were examined in 66 patients. After three weeks of therapy, heart rate and PR interval were increased (P<.02, P<.05), while prolongation of the QTc time and the QRS interval did not reach significant levels. We observed significant flattening of T waves (P<.05), which was not associated with changes in the serum potassium level. These changes were reversible after treatment was discontinued. When therapy was maintained for 13 months, only the heart rate continued to be increased, whereas all other ECG values had returned to normal. The TCA therapy led to a significant prolongation of the preejection period (P<.01) and slight shortening of the left ventricular ejection time, indicating a decrease in myocardial contractility. There was no difference of effects on the values studied between tricyclic and tetracyclic antidepressants.

(JAMA 239:213-216, 1978)

Footnotes

  • Reprint requests to Medical University Poliklinik, Hebelstrasse 1, CH-4056 Basel, Switzerland (Dr Burckhardt).

« Previous | Next Article »Table of Contents

More in JAMA & Archives Journals